tradepost.ai Logo
Newsletter InsightsSEC AnalysisAI Top20 IndexPricing
Log in
Start free trial
tradepost.ai Logo

Empowering Traders with AI

Quick Links

Newsletter InsightsSEC AnalysisPricingFAQ

Legal

Privacy PolicyCookies PolicySecurity Disclosure PolicyTerms & ConditionsDisclaimer

Copyright © 2025 Dutchcode B.V. All rights reserved.

10-Q - Healthcare AI Acquisition Corp. (0001848861) (Filer)

Thu, Jun 5, 8:17 PM (18 days ago)

**Healthcare AI Acquisition Corp. (HAIUF) Q1 2025 Financial Summary** **Financial Health & Performance:** - **Revenue:** No operational revenue generated; non-operating income from interest on investments. - **Profit Margins:** Negative; Q1 2025 net loss of $74,119, primarily due to operating costs and changes in warrant liability fair value. - **Cash Flow:** Positive cash flow from financing activities ($100,180) offset by negative cash flow from operating activities ($100,180). - **Earnings Changes:** Net loss decreased significantly from Q1 2024 ($466,716) to Q1 2025 ($74,119). **Quarterly Performance Discussion:** - **Trends:** Significant decrease in trust account balance due to share redemptions, leading to reduced interest income. - **Uncertainties:** Geopolitical risks and market volatility may impact future operations and business combination prospects. - **Future Operations:** Focus on completing the business combination with Leading Group Limited; potential challenges due to delisting from Nasdaq and "penny stock" status. **Key Metrics:** - **Cash on Hand:** $212 (Q1 2025 and 2024). - **Trust Account:** $4,758,369 (Q1 2025) vs. $4,664,536 (Q1 2024). - **Share Redemptions:** 246,676 shares redeemed in Q1 2025, removing $2,948,990 from the trust account. - **Shareholders' Deficit:** ($1,567,656) in Q1 2025 vs. ($1,399,704) in Q1 2024. **Outlook:** - **Business Combination:** Targeting completion by October 14, 2025; extensions approved by shareholders. - **Liquidity:** Concerns about sufficient cash to operate until the next 12 months without a business combination. - **Risks:** Potential delays or failures in the business combination, regulatory hurdles, and market conditions.